Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with severe sleep-disordered breathing (a condition where breathing is seriously disrupted during sleep)
- People who are expected to be able to handle the procedures involved in the study
- People who either do not have heart failure, or whose heart failure is medically stable
Who may not be able to join:
- People who already have a nerve-stimulating device implanted to treat sleep-disordered breathing, unless the trial sponsor gives special approval
- People with a history of severe chronic obstructive pulmonary disease (COPD) or high blood pressure in the arteries of the lungs
- People who have a history of nerve damage or nerve palsy (weakness or paralysis caused by nerve problems)
- People who have had previous surgery on the neck or radiation treatment to the head area
- People who are known to need an MRI scan
- People with a history of psychosis or severe bipolar disorder
- People who have had an active infection or blood infection (sepsis) within the 30 days before enrolling in the trial
- People who are currently on kidney dialysis or who have significantly reduced kidney function
- People whose hemoglobin (a measure of red blood cells) is below 8g/dl, which may indicate severe anaemia
- People whose heart depends entirely on a pacemaker to beat
- People who have had a new defibrillator, any implantable device, or a device battery replacement within 30 days before the study implant, or where this is expected to happen within the first 12 months of the trial
- People with other health conditions or planned surgeries that may affect their ability to complete the study
- People with an allergy to contrast dye (a substance sometimes used in medical imaging), unless the allergy can be managed with preventive treatment beforehand
- People who are pregnant or planning to become pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robin Germany, MD, ZOLL Respicardia
Phone: 205-441-9519
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety through 12 months; Successful Implantation; Improvement in sleep disordered breathing
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.